Found 83 matching trials
Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype PHASE3 The purpose of this study is to evaluate if a 12-week total regimen of tela...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB) PHASE2 This study is intended to evaluate if 12 or 24 weeks of treatment with GSK3...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection PHASE2 This is a randomized, open label, multicenter Phase 2 study investigating t...
Show More Location
Arizona Liver Health
Learn More & Join Trial
Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy PHASE4 The purpose of this study is to evaluate the impact of a physician directed...
Show More Location
California Liver Institute
Learn More & Join Trial
Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer PHASE2 RATIONALE: Drugs used in chemotherapy, such as capecitabine, work in differ...
Show More Learn More & Join Trial
A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms PHASE3 The purpose of the study is to compare the efficacy and toxicity including ...
Show More Location
Dept of Hematology, Aalborg hospital
Learn More & Join Trial
Antiviral Effect, Safety, and Pharmacokinetics of BI201335 +PegIFN/RBV in HCV-GT1 (SILEN-C1&2) PHASE2 The objective was to investigate the antiviral effect, safety, and pharmaco...
Show More Location
1220.5.0001 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relapsers EARLY_PHASE1 This is a non-randomized, open-label study examining the safety and efficac...
Show More Location
University of Nebraska Medical Center
Learn More & Join Trial
Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4 PHASE4 The study aims to study the outcome of pharmacokinetics-adjusted dose ribav...
Show More Location
King Faisal Specialist Hospital & Research Centre
Learn More & Join Trial
Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to Bitherapy PHASE1 This study is designed to evaluate the safety of biological active dose of ...
Show More Location
Kaohsiung Medical University Hospital
Learn More & Join Trial